521 related articles for article (PubMed ID: 24129463)
1. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial.
Abdallah MS; Wang K; Magnuson EA; Spertus JA; Farkouh ME; Fuster V; Cohen DJ;
JAMA; 2013 Oct; 310(15):1581-90. PubMed ID: 24129463
[TBL] [Abstract][Full Text] [Related]
2. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.
Cohen DJ; Van Hout B; Serruys PW; Mohr FW; Macaya C; den Heijer P; Vrakking MM; Wang K; Mahoney EM; Audi S; Leadley K; Dawkins KD; Kappetein AP;
N Engl J Med; 2011 Mar; 364(11):1016-26. PubMed ID: 21410370
[TBL] [Abstract][Full Text] [Related]
3. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
[TBL] [Abstract][Full Text] [Related]
4. Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.
Abdallah MS; Wang K; Magnuson EA; Osnabrugge RL; Kappetein AP; Morice MC; Mohr FA; Serruys PW; Cohen DJ;
J Am Coll Cardiol; 2017 Apr; 69(16):2039-2050. PubMed ID: 28427580
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial.
Magnuson EA; Farkouh ME; Fuster V; Wang K; Vilain K; Li H; Appelwick J; Muratov V; Sleeper LA; Boineau R; Abdallah M; Cohen DJ;
Circulation; 2013 Feb; 127(7):820-31. PubMed ID: 23277307
[TBL] [Abstract][Full Text] [Related]
6. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
7. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
8. Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study.
Kim H; Kang DY; Ahn JM; Lee J; Choi Y; Hur SH; Park HJ; Tresukosol D; Kang WC; Kwon HM; Rha SW; Lim DS; Jeong MH; Lee BK; Huang H; Lim YH; Bae JH; Kim BO; Ong TK; Ahn SG; Chung CH; Park DW; Park SJ;
JACC Cardiovasc Interv; 2023 Oct; 16(19):2412-2422. PubMed ID: 37821187
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
10. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.
Baron SJ; Chinnakondepalli K; Magnuson EA; Kandzari DE; Puskas JD; Ben-Yehuda O; van Es GA; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning A; Simonton CA; Kappetein AP; Sabik JF; Serruys PW; Stone GW; Cohen DJ;
J Am Coll Cardiol; 2017 Dec; 70(25):3113-3122. PubMed ID: 29097293
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
[TBL] [Abstract][Full Text] [Related]
12. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
[TBL] [Abstract][Full Text] [Related]
13. SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.
Esper RB; Farkouh ME; Ribeiro EE; Hueb W; Domanski M; Hamza TH; Siami FS; Godoy LC; Mathew V; French J; Fuster V
J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2826-2837. PubMed ID: 30522646
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
Chang M; Ahn JM; Lee CW; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
J Am Coll Cardiol; 2016 Jul; 68(1):29-36. PubMed ID: 27364047
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
Fearon WF; Zimmermann FM; Ding VY; Zelis JM; Piroth Z; Davidavicius G; Mansour S; Kharbanda R; Östlund-Papadogeorgos N; Oldroyd KG; Wendler O; Reardon MJ; Woo YJ; Yeung AC; Pijls NHJ; De Bruyne B; Desai M; Hlatky MA;
Circulation; 2022 May; 145(22):1655-1662. PubMed ID: 35369704
[TBL] [Abstract][Full Text] [Related]
17. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study.
Farkouh ME; Domanski M; Dangas GD; Godoy LC; Mack MJ; Siami FS; Hamza TH; Shah B; Stefanini GG; Sidhu MS; Tanguay JF; Ramanathan K; Sharma SK; French J; Hueb W; Cohen DJ; Fuster V;
J Am Coll Cardiol; 2019 Feb; 73(6):629-638. PubMed ID: 30428398
[TBL] [Abstract][Full Text] [Related]
19. External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI.
Takahashi K; Serruys PW; Fuster V; Farkouh ME; Spertus JA; Cohen DJ; Park SJ; Park DW; Ahn JM; Onuma Y; Kent DM; Steyerberg EW; van Klaveren D;
J Am Coll Cardiol; 2022 Apr; 79(15):1458-1473. PubMed ID: 35422242
[TBL] [Abstract][Full Text] [Related]
20. Quality of life following coronary artery bypass graft surgery vs. percutaneous coronary intervention in diabetics with multivessel disease: a five-year registry study.
McGrath BM; Norris CM; Hardwicke-Brown E; Welsh RC; Bainey KR
Eur Heart J Qual Care Clin Outcomes; 2017 Jul; 3(3):216-223. PubMed ID: 28838087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
